Time to raise the bar: Transition rate of phase 1 programs on anticancer drugs
Zhao, S; Wang, D; Zhao, HY; Gong, JF; Zhang, J; Fang, WF; Ma, F; Xu, BH; Li, J; Hu, XC; Ba, Y; Chen, XY; Yang, ZM; Shen, L; Jiang, JH; Zhang, L
Zhang, L (通讯作者)，Sun Yat Sen Univ, Sun Yat Sen Univ Canc Ctr, Zhongshan Sch Med,Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Dept Med Oncol, Guangzhou, Peoples R China.;Jiang, JH (通讯作者)，Pharmcube Co Ltd, Beijing, Peoples R China.;Shen, L (通讯作者)，Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ, Dept Gastrointestinal Oncol, Beijing, Peoples R China.
CANCER CELL, 2022; 40 (3): 233
